COMMUNIQUÉS West-GlobeNewswire

Flexion Therapeutics Names David Arkowitz as Chief Financial Officer

07/05/2018 - 13:30

BURLINGTON, Mass., May 07, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced that David Arkowitz has been named Chief Financial Officer (CFO). Mr. Arkowitz brings more than 25 years of [...]

Keryx Biopharmaceuticals to Host Conference Call of First Quarter 2018 Financial Results on Thursday, May 10, 2018

07/05/2018 - 13:30

BOSTON, May 07, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced that it will [...]

Share buy-back week 18/2018

07/05/2018 - 13:18

Announcement 7 May 2018 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up to [...]

Trading in Novo Nordisk shares by board members, executives and associated persons on 4 May 2018

07/05/2018 - 13:16

Bagsværd, Denmark, 7 May 2018 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of [...]

Mike Weinstein to Join Medtronic as Senior Vice President of Strategy

07/05/2018 - 12:01

DUBLIN - May 7, 2018 - Medtronic plc (NYSE: MDT ), the global leader in medical technology, today announced the appointment of Mike Weinstein as Senior Vice President, Strategy. In this role, Weinstein will work with [...]

Projects of decisions of Latvijas Juras medicinas centrs JSC Annual Shareholders’ Meeting on June, 12, 2018.

07/05/2018 - 11:52

Latvia, 2018-05-07 11:52 CEST (GLOBE NEWSWIRE) -- Projects of decisions of Latvijas Juras medicinas centrs JSC Annual Shareholders’ Meeting on June, 12, 2018. Member of the Board: Juris Imaks, phone: 29512492

NOTICE ON CONVENING OF ORDINARY SHAREHOLDER’S MEETING.

07/05/2018 - 09:52

Latvia, 2018-05-07 09:52 CEST (GLOBE NEWSWIRE) -- The Management Board of Latvijas Jūras medicīnas centrs JSC hereby makes an announcement on convening of an ordinary general meeting of shareholders on June 12, 2018 at [...]

Veritas Pharma Establishes New Subsidiary in Puerto Rico, USA

07/05/2018 - 09:10

VANCOUVER, British Columbia, May 07, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ), (“Veritas” or the “Company”) is pleased to announce the establishment of new subsidiary Veritas [...]

Ambu A/S: Interim report for Q2 2017/18 and for the half-year (1 October 2017- 31 March 2018)

07/05/2018 - 08:07

Reporting organic growth in Q2 of 15%, Ambu is well on the way to realising its Big Five 2020 targets with satisfactory gross margins and earnings. The organic growth outlook in local currencies for the year is raised [...]

OSE Immunotherapeutics Presents New Data on OSE-127 at the American Association of Immunologists (AAI) Annual Meeting May 4-8 2018 in Austin, Texas

07/05/2018 - 08:00

OSE-127 significantly decreases inflammation in colon biopsies from patients with inflammatory bowel diseases and enhances regulatory T-lymphocytes, the cells that fight inflammation. In patients with active mucosal [...]

Alcon Cares Project 100 Commits to Reducing Cataract Blindness Globally

07/05/2018 - 07:16

Alcon Cares to donate 100 reprocessed Infiniti ® units to clinics helping underserved patients in Asia, Central and South America, and Africa over the next three years Program to increase access to eye care and the [...]

Dentsply Sirona Reports First Quarter 2018 Results

07/05/2018 - 01:30

Reported Q1 revenues of $956.1 million, up 6.2% compared to prior year; constant currency growth 1 of negative 1.1% Q1 2018 GAAP EPS of $0.35 with Q1 2018 non-GAAP adjusted EPS of $0.45 Updated 2018 guidance: non-GAAP [...]

BrainsWay Receives FDA Clearance of Next Generation Stimulator, Enhancing Its Current Deep Transcranial Magnetic Stimulation (Deep TMS) System for Treatment of Major Depressive Disorder

06/05/2018 - 19:25

The company will now have the most advanced stimulator on the market, with enhanced features that increase the ease of use for physicians and integrate a patient management system BrainsWay will be demonstrating the new [...]

Cesca Therapeutics Inc. Presents New Data on its Proprietary X-Series™ Cellular Processing Systems

04/05/2018 - 23:00

Two posters presented at the International Society for Cellular Therapy (ISCT) 2018 Annual Meeting RANCHO CORDOVA, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the “Company”) (NASDAQ: [...]

BeiGene to Present at the Deutsche Bank 43rd Annual Health Care Conference

04/05/2018 - 22:15

CAMBRIDGE, Mass., and BEIJING, China, May 04, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly [...]

VIVUS Announces Date of 2018 Annual Meeting

04/05/2018 - 22:05

CAMPBELL, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS ) (the “Company”), a biopharmaceutical company, today announced that the Company will hold its 2018 Annual Meeting of Stockholders (the “2018 [...]

EY Announces OrthoPediatrics as Entrepreneur of The Year® 2018 Award Finalist in the Midwest

04/05/2018 - 22:01

WARSAW, Ind., May 04, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS ), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce that Ernst & Young (EY) has [...]

Sientra® to Release First Quarter 2018 Financial Results on Wednesday, May 9, 2018

04/05/2018 - 22:01

SANTA BARBARA, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN ), a medical aesthetics company (“Sientra or the “Company”), announced today that the Company will release its first quarter 2018 [...]

Oncolytics Biotech® Announces Voting Results from its Annual General Meeting of Shareholders

04/05/2018 - 22:00

CALGARY, Alberta and SAN DIEGO, May 04, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (TSX: ONC ) (OTCQX:ONCYF), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic virus [...]